Beacon Investment Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.5M	Sell	53,380 -2,724	-5%	-$1.21M	0.98%	31
2026 Q1	$25.1M	Sell	56,104 -17,989	-24%	-$8.39M	1.03%	29
2025 Q4	$33.6M	Sell	74,093 -2,049	-3%	-$883K	1.37%	18
2025 Q3	$29.8M	Sell	76,142 -889	-1%	-$372K	1.25%	21
2025 Q2	$34.3M	Sell	77,031 -870	-1%	-$401K	1.51%	18
2025 Q1	$37.8M	Sell	77,901 -923	-1%	-$430K	1.77%	11
2024 Q4	$31.7M	Sell	78,824 -347	-0.4%	-$161K	1.38%	21
2024 Q3	$36.8M	Sell	79,171 -61	-0.1%	-$29.3K	1.53%	20
2024 Q2	$37.1M	Buy	79,232 +1,515	+2%	+$658K	1.59%	20
2024 Q1	$32.5M	Sell	77,717 -203	-0.3%	-$85.8K	1.4%	21
2023 Q4	$31.7M	Buy	77,920 +1,679	+2%	+$620K	1.44%	22
2023 Q3	$26.5M	Buy	76,241 +1,968	+3%	+$688K	1.31%	24
2023 Q2	$26.1M	Buy	74,273 +265	+0.4%	+$89.3K	1.2%	25
2023 Q1	$23.3M	Sell	74,008 -832	-1%	-$250K	1.13%	27
2022 Q4	$21.6M	Buy	74,840 +423	+0.6%	+$129K	1.11%	26
2022 Q3	$21.5M	Sell	74,417 -455	-0.6%	-$131K	1.19%	26
2022 Q2	$21.1M	Buy	74,872 +1,779	+2%	+$476K	1.1%	27
2022 Q1	$19.1M	Buy	73,093 +42,536	+139%	+$10.1M	0.81%	36
2021 Q4	$6.71M	Sell	30,557 -5,945	-16%	-$1.16M	0.26%	80
2021 Q3	$6.62M	Sell	36,502 -398	-1%	-$77.7K	0.27%	83
2021 Q2	$7.44M	Sell	36,900 -745	-2%	-$156K	0.3%	76
2021 Q1	$8.09M	Buy	37,645 +202	+0.5%	+$44.4K	0.35%	69
2020 Q4	$8.85M	Sell	37,443 -1,709	-4%	-$392K	0.41%	64
2020 Q3	$10.7M	Buy	39,152 +709	+2%	+$196K	0.55%	54
2020 Q2	$11.2M	Buy	38,443 +13,060	+51%	+$3.54M	0.64%	48
2020 Q1	$6.04M	Buy	+25,383	New	+$5.82M	0.43%	63

Other funds holding VRTX